J. Trujillo

发表

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist

Jennifer M. Trujillo, C. Triplitt, Dhiren Patel, 2019, Advances in Therapy.

Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin

Eric L. Johnson, Jennifer M. Trujillo, J. Frias, 2018, Postgraduate medicine.

The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes

Jennifer M. Trujillo, T. Trujillo, S. Linnebur, 2016, American Journal of Pharmaceutical Education.

Initial Management of Severe Hyperglycemia in Patients with Type 2 Diabetes: an Observational Study

Jennifer M. Trujillo, M. Mcdermott, J. Trujillo, 2013, Diabetes Therapy.

Impact of Sodium‐Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2017, Pharmacotherapy.

Switching basal insulins in type 2 diabetes: practical recommendations for health care providers

Jennifer M. Trujillo, John E. Anderson, J. Trujillo, 2018, Postgraduate medicine.

Follow-up Assessment of a Faculty Peer Observation and Evaluation Program

Jenny A Van Amburgh, D. Qualters, J. Trujillo, 2012, American Journal of Pharmaceutical Education.

Oral semaglutide in type 2 diabetes.

Jennifer M. Trujillo, J. Trujillo, Sarah L. Anderson, 2020, Journal of diabetes and its complications.

A review of sotagliflozin for use in type 1 diabetes

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2019, Therapeutic advances in endocrinology and metabolism.

Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes

Jennifer M. Trujillo, A. Thompson, J. Trujillo, 2018, The Annals of pharmacotherapy.

Role of combination therapy or coformulation products in treatment of type 2 diabetes

Jennifer M. Trujillo, J. Trujillo, 2018, Pharmacy Today.

The Role of Inhaled Insulin in the Management of Type 2 Diabetes

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2016 .

Advances in the treatment of type 2 diabetes: impact of dulaglutide

Jennifer M. Trujillo, A. Thompson, J. Trujillo, 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.

Basal Insulin Use With GLP-1 Receptor Agonists

Jennifer M. Trujillo, J. Trujillo, Sarah L. Anderson, 2016, Diabetes Spectrum.

Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2014, The Annals of pharmacotherapy.

Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline

Jennifer M. Trujillo, James Chamberlain, J. Shubrook, 2020, Annals of Internal Medicine.

Technosphere Insulin (Afrezza)

Wesley Nuffer, S. Ellis, J. Trujillo, 2015, The Annals of pharmacotherapy.

Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.

Jennifer M. Trujillo, A. Thompson, J. Trujillo, 2015, The Annals of pharmacotherapy.

Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone

Jennifer M. Trujillo, J. Lasalle, T. Dex, 2018, Diabetes, obesity & metabolism.

Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy

Jennifer M. Trujillo, J. Trujillo, Kali B Turrin, 2019, Diabetes Therapy.

Teaching and Learning Health Literacy in a Doctor of Pharmacy Program

Jennifer M. Trujillo, J. Trujillo, Trista A Figler, 2015, American Journal of Pharmaceutical Education.

GLP-1 receptor agonists: a review of head-to-head clinical studies

Jennifer M. Trujillo, Wesley Nuffer, S. Ellis, 2015, Therapeutic advances in endocrinology and metabolism.

GLP‐1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2014, Pharmacotherapy.

Lixisenatide, a Once‐Daily Prandial Glucagon‐Like Peptide‐1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes

Jennifer M. Trujillo, J. Trujillo, J. Goldman, 2017, Pharmacotherapy.

GLP-1 receptor agonists: an updated review of head-to-head clinical studies

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2021, Therapeutic advances in endocrinology and metabolism.

Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices

Jennifer M. Trujillo, J. Trujillo, A. Zhou, 2018, Diabetes Spectrum.

Drug Information Rounds

Jennifer M. Trujillo, J. Trujillo, Sarah L. Anderson, 1997 .

Report of the 2015-2016 Academic Affairs Standing Committee

Cecilia M. Plaza, Jennifer M. Trujillo, A. Pittenger, 2016, American Journal of Pharmaceutical Education.

Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist.

Jennifer M. Trujillo, Wesley Nuffer, J. Trujillo, 2022, Journal of diabetes and its complications.

Effects of Pioglitazone or Exercise in Older Adults with Mild Cognitive Impairment and Insulin Resistance: A Pilot Study

Jennifer M. Trujillo, K. Moreau, R. Schwartz, 2015, Dementia and Geriatric Cognitive Disorders Extra.

A Nutrition Journal and Diabetes Shopping Experience to improve pharmacy students' empathy and cultural competence.

J. Trujillo, Y. Hardy, 2009, American journal of pharmaceutical education.

Core Entrustable Professional Activities for New Pharmacy Graduates

Melissa S Medina, Cecilia M. Plaza, Jennifer M. Trujillo, 2017, American Journal of Pharmaceutical Education.